Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Instagram Outage Disrupts Thousands of U.S. Users 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
BOSTON, Jan. 02, 2018 -- Choate today announced that Emily Hodge and Dr. Rolando Medina have been elevated to partner, effective January 1, 2018.
As a partner in the Firm’s Government Enforcement group, Ms. Hodge will continue representing individuals and life sciences companies in government and internal investigations and providing compliance advice to companies that are navigating a challenging and nuanced enforcement environment.
In 2017 Ms. Hodge was honored by the Boston Business Journal as one of Boston’s 40 Under 40 emerging business leaders. She received her JD, cum laude, from Georgetown University Law School in 2006 and her AB, cum laude, from Harvard University in 2002.
As a partner in the Firm’s Intellectual Property and Life Sciences groups, Dr. Medina will continue to represent start-up, mid-sized and large biotechnology and pharmaceutical companies in intellectual property matters, providing clients with strategic advice in patent prosecution and portfolio management, post-grant proceedings, opinions, due diligence analyses, and licensing.
In 2017, Dr. Medina was recognized as an IP Star by LMG Life Sciences and named to Who's Who Legal’s list of top Life Sciences transactional attorneys. He received his JD, cum laude, from the University of Pittsburgh School of Law in 2003, his PhD in 1999 from Yale University and his BS, magna cum laude, in Biology and Chemistry from Westminster College of Salt Lake City.
Contact:
Matt Weaver
Choate, Hall & Stewart LLP
[email protected]
(617) 248-4001
